顔用注射剤の世界市場レポート 2025年

顔用注射剤市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.4％で226億5,000万米ドルに成長します。予測期間の成長は、非外科的処置に対する需要の高まり、アプリケーションの拡大、パーソナライゼーションとカスタマイズ化、新興市場、ヘルスケア動向、ライフスタイルの変化に起因すると考えられます。予測期間の主な動向としては、非外科的処置に対する需要の継続的な伸び、個別化された治療アプローチの拡大、治療効果を高めるための併用療法への注目の高まり、低侵襲技術や機器の台頭、自然な仕上がりや繊細な仕上がりへのシフトなどが挙げられます。

美容施術への関心の高まりが、今後数年間の顔用注射剤市場の成長を牽引すると予想されます。美容整形は、身体の自然な構造への影響を最小限に抑えながら見た目の美しさを向上させることを目的とした治療を包含しており、多くの場合、従来の手術よりも侵襲性が低く、一般的に外来患者ベースで行われます。このような需要は、外見に対する社会の注目、医学の進歩によって可能になったより安全で利用しやすい施術、自己改善と自信向上への欲求の高まりによって増加しています。顔面注入剤は、ボツリヌス毒素や皮膚充填剤のような物質を正確に注入することにより、一時的にしわを減らし、特定の部位にボリュームを加え、顔の輪郭を改善する美容施術に使用されます。例えば、2023年3月、英国美容整形外科医協会（British Association of Aesthetic Plastic Surgeons）の報告によると、2022年の英国における美容整形手術件数は、2021年と比較して102％増加し、約3万1,057件に達しました。このように、美容整形に対する需要の高まりが顔用注射剤市場の成長を後押ししています。

顔用注射剤市場の主要企業は、自然な外観と持続的な結果を提供する低侵襲の美容施術の需要に応えるため、長持ちするヒアルロン酸（HA）フィラーなどの製品で革新を進めています。HAフィラーは、天然の皮膚物質を補充することにより、ボリュームを回復し、しわを滑らかにし、顔の輪郭を強調します。例えば、2023年1月、Allergan plcはJUVEDERM VOLUX XCを発表しました。このHAフィラーは、中等度から重度の輪郭欠損を持つ21歳以上の人々のために、顎のラインを引き締めるよう特別にデザインされたものです。JUVEDERM VOLUX XCは、最大12カ月間効果が持続し、ダウンタイムを最小限に抑えながら自然な仕上がりを実現するため、非外科的な選択肢を求める患者にとって魅力的です。調査と高い患者満足度に支えられたこのフィラーは、美容専門医によるカスタマイズされた治療計画を可能にします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界顔用注射剤PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の顔用注射剤市場：成長率分析
• 世界の顔用注射剤市場の実績：規模と成長, 2019-2024
• 世界の顔用注射剤市場の予測：規模と成長, 2024-2029, 2034F
• 世界顔用注射剤総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の顔用注射剤市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ボツリヌス毒素
• コラーゲン
• ヒアルロン酸
• カルシウムハイドロキシアパタイト
• ポリ乳酸
• ポリメチルメタクリレートマイクロスフィア（PMMA）
• 脂肪注入
• その他のタイプ
• 世界の顔用注射剤市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• しわの軽減
• フェイスリフト
• ニキビ跡の治療
• 脂肪萎縮症の治療
• 唇の強調
• その他の用途
• 世界の顔用注射剤市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院および外来手術センター
• 皮膚科・美容クリニック
• その他のエンドユーザー
• 世界の顔用注射剤市場ボツリヌス毒素の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• A型ボツリヌス毒素（ボトックス、ディスポート、ゼオミン）
• ボツリヌス毒素B型（ミオブロック、ニューロブロック）
• 世界の顔用注射剤市場コラーゲンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 牛コラーゲン
• ヒトコラーゲン
• 合成コラーゲン
• 世界の顔用注射剤市場ヒアルロン酸の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 架橋ヒアルロン酸
• 非架橋ヒアルロン酸
• 世界の顔用注射剤市場カルシウムハイドロキシアパタイトの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ラディアス（カルシウムハイドロキシアパタイトベースの充填剤）
• 世界の顔用注射剤市場ポリ乳酸の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• スカルプトラ（ポリ乳酸系フィラー）
• 世界の顔用注射剤市場ポリメチルメタクリレートマイクロスフィア（PMMA）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アルテフィル（PMMAベースの充填剤）
• 世界の顔用注射剤市場脂肪注入の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自家脂肪移植（脂肪吸引と注入）
• ボリューム回復のための脂肪移植
• 世界の顔用注射剤市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポリ-L-乳酸
• ポリカプロラクトン系充填剤
• その他の新興注入剤

第7章 地域別・国別分析

• 世界の顔用注射剤市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の顔用注射剤市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 顔用注射剤市場：競合情勢
• 顔用注射剤市場：企業プロファイル
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Ipsen Pharma Overview, Products and Services, Strategy and Financial Analysis
  • Galderma S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Merz Pharma GmbH & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sinclair Pharma Plc
• Revance Therapeutics Inc.
• Suneva Medical Inc.
• Prollenium Medical Technologies
• SciVision Biotech Inc.
• Anteis S.A.
• Anika Therapeutics Inc.
• Q-Med AB
• Bloomage BioTechnology
• Medytox Inc.
• Teoxane Laboratories
• Alphaeon Corporation
• BIOPLUS CO. LTD.
• BioPolymer GmbH & Co. KG
• Bioxis Pharmaceuticals

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 顔用注射剤市場2029：新たな機会を提供する国
• 顔用注射剤市場2029：新たな機会を提供するセグメント
• 顔用注射剤市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Facial injectables are cosmetic procedures that involve injecting substances into facial tissues to enhance features, diminish wrinkles, restore volume, or enhance overall appearance without surgery. These treatments are commonly used to address aging signs or achieve specific aesthetic goals, offering results that are temporary or semi-permanent.

The primary types of facial injectables include botulinum toxin, collagen, hyaluronic acid, calcium hydroxyapatite, polylactic acid, polymethyl-methacrylate microspheres (PMMA), fat injection, and others. Botulinum toxin is a neurotoxic protein used in cosmetic procedures to temporarily relax muscle activity, primarily for reducing facial wrinkles and lines. These injectables serve various purposes such as wrinkle reduction, facelifts, acne scar treatment, lipoatrophy treatment, lip enhancement, and more. They are used by different end-users including hospitals, ambulatory surgery centers, dermatology and cosmetic clinics, among others.

The facial injectable market research report is one of a series of new reports from The Business Research Company that provides facial injectable market statistics, including facial injectable industry global market size, regional shares, competitors with a facial injectable market share, detailed facial injectable market segments, market trends and opportunities, and any further data you may need to thrive in the facial injectable industry. This facial injectable market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The facial injectable market size has grown rapidly in recent years. It will grow from $13.74 billion in 2024 to $15.22 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to the increased aging population, growth in consumer awareness, shift in beauty standards, regulatory approvals, and advancements in injection techniques.

The facial injectable market size is expected to see rapid growth in the next few years. It will grow to $22.65 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to rising demand for non-surgical procedures, expanding applications, personalization and customization, emerging markets, healthcare trends, and lifestyle changes. Major trends in the forecast period include continued growth in demand for non-surgical procedures, expansion of personalized treatment approaches, increasing focus on combination therapies for enhanced outcomes, the rise of minimally invasive techniques and devices, and a shift towards natural-looking and subtle results.

The rising interest in cosmetic procedures is expected to drive the growth of the facial injectable market in the coming years. Cosmetic procedures encompass medical treatments aimed at enhancing appearance with minimal disruption to the body's natural structure, often less invasive than traditional surgeries and typically performed on an outpatient basis. This demand is increasing due to societal focus on appearance, safer and more accessible procedures enabled by medical advancements, and a growing desire for self-improvement and confidence boost. Facial injectables are used in cosmetic procedures to temporarily reduce wrinkles, add volume to specific areas, and improve facial contours through precise injection of substances such as botulinum toxin or dermal fillers. For example, in March 2023, a report from the British Association of Aesthetic Plastic Surgeons noted a 102% increase in cosmetic procedures in the UK in 2022, reaching around 31,057 procedures, compared to 2021. Thus, the rising demand for cosmetic procedures is fueling the growth of the facial injectable market.

Leading companies in the facial injectable market are innovating with products such as long-lasting hyaluronic acid (HA) fillers to meet the demand for minimally invasive aesthetic procedures offering natural-looking and enduring results. HA fillers restore volume, smooth wrinkles, and enhance facial contours by replenishing natural skin substances. For instance, in January 2023, Allergan plc introduced JUVEDERM VOLUX XC, an HA filler specifically designed to enhance jawline definition for individuals aged 21 and above with moderate to severe contour loss. Providing effects lasting up to twelve months, JUVEDERM VOLUX XC delivers natural-looking results with minimal downtime, appealing to patients seeking non-surgical options. Supported by research and high patient satisfaction, this filler enables customized treatment plans by cosmetic specialists.

In October 2022, Prollenium Medical Technologies acquired SoftFil for an undisclosed amount, expanding its product range and enhancing its position in the aesthetic medicine industry. This acquisition strengthens innovation and offers comprehensive solutions to practitioners for optimal patient outcomes. SoftFil, a France-based company, produces cosmetic products, aesthetic microcannulas, and facial injectable solutions, complementing Prollenium's portfolio.

Major companies operating in the facial injectable market are AbbVie Inc., Sanofi S.A., Ipsen Pharma, Galderma S.A., Merz Pharma GmbH & Co. KGaA, Sinclair Pharma Plc, Revance Therapeutics Inc., Suneva Medical Inc., Prollenium Medical Technologies, SciVision Biotech Inc., Anteis S.A., Anika Therapeutics Inc., Q-Med AB, Bloomage BioTechnology, Medytox Inc., Teoxane Laboratories, Alphaeon Corporation, BIOPLUS CO. LTD., BioPolymer GmbH & Co. KG, Bioxis Pharmaceuticals, Everest Pharmaceuticals

North America was the largest region in the facial injectable market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the facial injectable market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the facial injectable market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The facial injectable market consists of sales of platelet-rich plasma (PRP) injections, collagen stimulators, lip injections, and thread lifts. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Facial Injectable Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on facial injectable market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for facial injectable ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The facial injectable market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Botulinum Toxin; Collagen; Hyaluronic Acid; Calcium Hydroxyapatite; Polylactic Acid; Polymethyl-Methacrylate Microspheres (PMMA); Fat Injection; Other Types
• 2) By Application: Wrinkle Reduction; Facelift; Acne Scar Treatment; Lipoatrophy Treatment; Lip Enhancement; Other Applications
• 3) By End-User: Hospitals And Ambulatory Surgery Centers; Dermatology And Cosmetic Clinics; Other End-Users
• Subsegments:
• 1) By Botulinum Toxin: Botulinum Toxin Type A (Botox, Dysport, Xeomin); Botulinum Toxin Type B (Myobloc, Neurobloc)
• 2) By Collagen: Bovine Collagen; Human Collagen; Synthetic Collagen
• 3) By Hyaluronic Acid: Cross-linked Hyaluronic Acid; Non-Cross-Linked Hyaluronic Acid
• 4) By Calcium Hydroxyapatite: Radiesse (Calcium Hydroxyapatite-Based Fillers)
• 5) By Polylactic Acid: Sculptra (Polylactic Acid-Based Fillers)
• 6) By Polymethyl Methacrylate Microspheres (PMMA): Artefill (PMMA-Based Fillers)
• 7) By Fat Injection: Autologous Fat Transfer (Liposuction And Injection); Fat Grafting For Volume Restoration
• 8) By Other Types: Poly-L-Lactic Acid; Polycaprolactone-Based Fillers; Other Emerging Injectable Fillers
• Companies Mentioned: AbbVie Inc.; Sanofi S.A.; Ipsen Pharma; Galderma S.A.; Merz Pharma GmbH & Co. KGaA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Facial Injectable Market Characteristics

3. Facial Injectable Market Trends And Strategies

4. Facial Injectable Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Facial Injectable Growth Analysis And Strategic Analysis Framework

• 5.1. Global Facial Injectable PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Facial Injectable Market Growth Rate Analysis
• 5.4. Global Facial Injectable Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Facial Injectable Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Facial Injectable Total Addressable Market (TAM)

6. Facial Injectable Market Segmentation

• 6.1. Global Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Botulinum Toxin
• Collagen
• Hyaluronic Acid
• Calcium Hydroxyapatite
• Polylactic Acid
• Polymethyl-Methacrylate Microspheres (PMMA)
• Fat Injection
• Other Types
• 6.2. Global Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Wrinkle Reduction
• Facelift
• Acne Scar Treatment
• Lipoatrophy Treatment
• Lip Enhancement
• Other Applications
• 6.3. Global Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Ambulatory Surgery Centers
• Dermatology And Cosmetic Clinics
• Other End-Users
• 6.4. Global Facial Injectable Market, Sub-Segmentation Of Botulinum Toxin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Botulinum Toxin Type A (Botox, Dysport, Xeomin)
• Botulinum Toxin Type B (Myobloc, Neurobloc)
• 6.5. Global Facial Injectable Market, Sub-Segmentation Of Collagen, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bovine Collagen
• Human Collagen
• Synthetic Collagen
• 6.6. Global Facial Injectable Market, Sub-Segmentation Of Hyaluronic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cross-linked Hyaluronic Acid
• Non-Cross-Linked Hyaluronic Acid
• 6.7. Global Facial Injectable Market, Sub-Segmentation Of Calcium Hydroxyapatite, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Radiesse (Calcium Hydroxyapatite-Based Fillers)
• 6.8. Global Facial Injectable Market, Sub-Segmentation Of Polylactic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sculptra (Polylactic Acid-Based Fillers)
• 6.9. Global Facial Injectable Market, Sub-Segmentation Of Polymethyl Methacrylate Microspheres (PMMA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Artefill (PMMA-Based Fillers)
• 6.10. Global Facial Injectable Market, Sub-Segmentation Of Fat Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Autologous Fat Transfer (Liposuction And Injection)
• Fat Grafting For Volume Restoration
• 6.11. Global Facial Injectable Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Poly-L-Lactic Acid
• Polycaprolactone-Based Fillers
• Other Emerging Injectable Fillers

7. Facial Injectable Market Regional And Country Analysis

• 7.1. Global Facial Injectable Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Facial Injectable Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Facial Injectable Market

• 8.1. Asia-Pacific Facial Injectable Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Facial Injectable Market

• 9.1. China Facial Injectable Market Overview
• 9.2. China Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Facial Injectable Market

• 10.1. India Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Facial Injectable Market

• 11.1. Japan Facial Injectable Market Overview
• 11.2. Japan Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Facial Injectable Market

• 12.1. Australia Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Facial Injectable Market

• 13.1. Indonesia Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Facial Injectable Market

• 14.1. South Korea Facial Injectable Market Overview
• 14.2. South Korea Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Facial Injectable Market

• 15.1. Western Europe Facial Injectable Market Overview
• 15.2. Western Europe Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Facial Injectable Market

• 16.1. UK Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Facial Injectable Market

• 17.1. Germany Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Facial Injectable Market

• 18.1. France Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Facial Injectable Market

• 19.1. Italy Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Facial Injectable Market

• 20.1. Spain Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Facial Injectable Market

• 21.1. Eastern Europe Facial Injectable Market Overview
• 21.2. Eastern Europe Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Facial Injectable Market

• 22.1. Russia Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Facial Injectable Market

• 23.1. North America Facial Injectable Market Overview
• 23.2. North America Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Facial Injectable Market

• 24.1. USA Facial Injectable Market Overview
• 24.2. USA Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Facial Injectable Market

• 25.1. Canada Facial Injectable Market Overview
• 25.2. Canada Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Facial Injectable Market

• 26.1. South America Facial Injectable Market Overview
• 26.2. South America Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Facial Injectable Market

• 27.1. Brazil Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Facial Injectable Market

• 28.1. Middle East Facial Injectable Market Overview
• 28.2. Middle East Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Facial Injectable Market

• 29.1. Africa Facial Injectable Market Overview
• 29.2. Africa Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Facial Injectable Market Competitive Landscape And Company Profiles

• 30.1. Facial Injectable Market Competitive Landscape
• 30.2. Facial Injectable Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Ipsen Pharma Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Galderma S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Merz Pharma GmbH & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Facial Injectable Market Other Major And Innovative Companies

• 31.1. Sinclair Pharma Plc
• 31.2. Revance Therapeutics Inc.
• 31.3. Suneva Medical Inc.
• 31.4. Prollenium Medical Technologies
• 31.5. SciVision Biotech Inc.
• 31.6. Anteis S.A.
• 31.7. Anika Therapeutics Inc.
• 31.8. Q-Med AB
• 31.9. Bloomage BioTechnology
• 31.10. Medytox Inc.
• 31.11. Teoxane Laboratories
• 31.12. Alphaeon Corporation
• 31.13. BIOPLUS CO. LTD.
• 31.14. BioPolymer GmbH & Co. KG
• 31.15. Bioxis Pharmaceuticals

32. Global Facial Injectable Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Facial Injectable Market

34. Recent Developments In The Facial Injectable Market

35. Facial Injectable Market High Potential Countries, Segments and Strategies

• 35.1 Facial Injectable Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Facial Injectable Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Facial Injectable Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer